Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Extensively drug-resistant tuberculosis: early access to bedaquiline for a UK patient.

van Halsema C, Humphreys S, Bonington A.

Eur Respir J. 2014 Jan;43(1):292-4. doi: 10.1183/09031936.00128613. Epub 2013 Aug 29. No abstract available.

2.

Bedaquiline in MDR/XDR-TB cases: first experience on compassionate use.

Tiberi S, De Lorenzo S, Centis R, Viggiani P, D'Ambrosio L, Migliori GB.

Eur Respir J. 2014 Jan;43(1):289-92. doi: 10.1183/09031936.00122313. Epub 2013 Aug 29. No abstract available.

3.

Compassionate use of bedaquiline in the treatment of pulmonary XDR-TB.

Danckers M, Lesko MB, Adamson R, Leibert E.

Int J Tuberc Lung Dis. 2014 Dec;18(12):1522-3. doi: 10.5588/ijtld.14.0338. No abstract available.

PMID:
25517823
4.

Compassionate use of bedaquiline for the treatment of multidrug-resistant and extensively drug-resistant tuberculosis: interim analysis of a French cohort.

Guglielmetti L, Le Dû D, Jachym M, Henry B, Martin D, Caumes E, Veziris N, Métivier N, Robert J; MDR-TB Management Group of the French National Reference Center for Mycobacteria and the Physicians of the French MDR-TB Cohort.

Clin Infect Dis. 2015 Jan 15;60(2):188-94. doi: 10.1093/cid/ciu786. Epub 2014 Oct 15.

5.

Compassionate and optimum use of new tuberculosis drugs.

Matteelli A, D'Ambrosio L, Centis R, Tadolini M, Migliori GB.

Lancet Infect Dis. 2015 Oct;15(10):1131-2. doi: 10.1016/S1473-3099(15)00296-0. Epub 2015 Sep 20. No abstract available.

PMID:
26461941
6.

Compassionate and optimum use of new tuberculosis drugs.

Reed C, Mason L, Cox H, Seaworth B, Lessem E, Furin J.

Lancet Infect Dis. 2015 Oct;15(10):1131; discussion 1131. doi: 10.1016/S1473-3099(15)00294-7. Epub 2015 Sep 20. No abstract available.

PMID:
26461942
7.

Initial experience of bedaquiline use in a series of drug-resistant tuberculosis patients from India.

Udwadia ZF, Amale RA, Mullerpattan JB.

Int J Tuberc Lung Dis. 2014 Nov;18(11):1315-8. doi: 10.5588/ijtld.14.0284.

PMID:
25299863
8.

Bedaquiline: a new drug approved for treatment of multidrug-resistant tuberculosis.

Deoghare S.

Indian J Pharmacol. 2013 Sep-Oct;45(5):536-7. doi: 10.4103/0253-7613.117765. No abstract available.

9.

Bedaquiline for the treatment of drug-resistant tuberculosis.

Bélard S, Heuvelings CC, Janssen S, Grobusch MP.

Expert Rev Anti Infect Ther. 2015 May;13(5):535-53. doi: 10.1586/14787210.2015.1021785. Epub 2015 Mar 22. Review.

PMID:
25797824
10.

Provisional CDC guidelines for the use and safety monitoring of bedaquiline fumarate (Sirturo) for the treatment of multidrug-resistant tuberculosis.

Centers for Disease Control and Prevention.

MMWR Recomm Rep. 2013 Oct 25;62(RR-09):1-12. Erratum in: MMWR Recomm Rep. 2013 Nov 15;62(45):906.

11.

Novel drugs against tuberculosis: a clinician's perspective.

Olaru ID, von Groote-Bidlingmaier F, Heyckendorf J, Yew WW, Lange C, Chang KC.

Eur Respir J. 2015 Apr;45(4):1119-31. doi: 10.1183/09031936.00162314. Epub 2014 Nov 27. Review.

PMID:
25431273
12.

FDA approval of bedaquiline--the benefit-risk balance for drug-resistant tuberculosis.

Cox E, Laessig K.

N Engl J Med. 2014 Aug 21;371(8):689-91. doi: 10.1056/NEJMp1314385. No abstract available.

13.

Multidrug-resistant tuberculosis and bedaquiline.

Salfinger M, Somoskövi A.

N Engl J Med. 2014 Dec 18;371(25):2435-6. doi: 10.1056/NEJMc1412235#SA1. No abstract available.

PMID:
25517715
14.

Multidrug-resistant tuberculosis and bedaquiline.

Diacon AH, Lounis N, Dannemann B.

N Engl J Med. 2014 Dec 18;371(25):2436. doi: 10.1056/NEJMc1412235. No abstract available.

15.

Doing the right thing for tuberculosis control in the Torres Strait Islands.

Konstantinos A, Simpson G, Sorrell T, Marais BJ.

Med J Aust. 2011 Nov 7;195(9):512. No abstract available.

PMID:
22060076
16.

A review of tuberculosis: Focus on bedaquiline.

Chan B, Khadem TM, Brown J.

Am J Health Syst Pharm. 2013 Nov 15;70(22):1984-94. doi: 10.2146/ajhp130199. Review.

PMID:
24173008
17.

Current issues with the use of bedaquiline.

Kakkar AK, Dahiya N.

Ann Pharmacother. 2014 May;48(5):666. doi: 10.1177/1060028014521589. Epub 2014 Feb 11. No abstract available.

PMID:
24519480
18.

Verapamil increases the bactericidal activity of bedaquiline against Mycobacterium tuberculosis in a mouse model.

Gupta S, Tyagi S, Bishai WR.

Antimicrob Agents Chemother. 2015 Jan;59(1):673-6. doi: 10.1128/AAC.04019-14. Epub 2014 Oct 20.

19.

Extensively drug-resistant tuberculosis: New Zealand's first case and the challenges of management in a low-prevalence country.

Goh TL, Towns CR, Jones KL, Freeman JT, Wong CS.

Med J Aust. 2011 Jun 6;194(11):602-4.

PMID:
21644877
20.

Multidrug- and extensively drug-resistant tuberculosis, Germany.

Eker B, Ortmann J, Migliori GB, Sotgiu G, Muetterlein R, Centis R, Hoffmann H, Kirsten D, Schaberg T, Ruesch-Gerdes S, Lange C; German TBNET Group.

Emerg Infect Dis. 2008 Nov;14(11):1700-6. doi: 10.3201/eid1411.080729.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk